Subcutaneous dematiaceous fungal infection.
Subcutaneous dematiaceous fungal infections, which include chromoblastomycosis and phaeohyphomycosis, are a heterogeneous group of clinical entities that are caused by dematiaceous or pigmented fungi found in soil. These infections have a wide spectrum of clinical presentations that depend largely on the specific causative organism and on the integrity of the host's immune response. Treatment is challenging and involves a highly individualized plan that often combines both surgical and long-term medical treatment.
Department of Dermatology, New York University, New York, New York, USA.
Utpal
U
Patel
Julie
J
Chu
Rishi
R
Patel
Shane
S
Meehan
D058186:Acute Kidney Injury / Q000139:chemically induced; D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002862:Chromoblastomycosis / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D003364:Costa Rica / Q000208:ethnology; D003937:Diagnosis, Differential; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D017964:Itraconazole / Q000627:therapeutic use; D016030:Kidney Transplantation; D007866:Leg; D008297:Male; D060446:Phaeohyphomycosis / Q000175:diagnosis; D011014:Pneumonia / Q000150:complications; D011743:Pyrimidines / Q000627:therapeutic use; D012988:Soil Microbiology; D014230:Triazoles / Q000627:therapeutic use; D065819:Voriconazole
D000935:Antifungal Agents; D007166:Immunosuppressive Agents; D011743:Pyrimidines; D014230:Triazoles; D017964:Itraconazole; D000666:Amphotericin B; D065819:Voriconazole